Cue Biopharma, Inc. (CUE) Operating income 2017–2025
Cue Biopharma, Inc. (CUE) annual operating income history from SEC filings — each fiscal year as reported.
-$26.6MFY2025 · since FY2017: -$23.2M → -$26.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.6M | +36.0% |
| FY2024 | -$41.5M | +20.4% |
| FY2023 | -$52.1M | +2.0% |
| FY2022 | -$53.2M | -21.8% |
| FY2021 | -$43.7M | +3.0% |
| FY2020 | -$45.0M | -22.5% |
| FY2019 | -$36.8M | +5.0% |
| FY2018 | -$38.7M | -66.6% |
| FY2017 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice